MFG
IBB icon

Magnus Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

Magnus Financial Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
8,556
+764
+10% +$131K 0.12% 120
2026
Q1 		$1.32M Buy
7,792
+1,124
+17% +$192K 0.11% 132
2025
Q4 		$1.13M Buy
6,668
+616
+10% +$100K 0.09% 157
2025
Q3 		$874K Sell
6,052
-4,901
-45% -$669K 0.07% 180
2025
Q2 		$1.39M Buy
10,953
+436
+4% +$53.5K 0.12% 129
2025
Q1 		$1.35M Sell
10,517
-2,450
-19% -$332K 0.13% 125
2024
Q4 		$1.71M Buy
12,967
+104
+0.8% +$14.6K 0.17% 104
2024
Q3 		$1.87M Buy
12,863
+2,137
+20% +$309K 0.19% 94
2024
Q2 		$1.47M Sell
10,726
-830
-7% -$111K 0.17% 102
2024
Q1 		$1.59M Buy
11,556
+837
+8% +$114K 0.19% 94
2023
Q4 		$1.46M Sell
10,719
-1,121
-9% -$137K 0.19% 89
2023
Q3 		$1.45M Sell
11,840
-965
-8% -$123K 0.21% 79
2023
Q2 		$1.63M Buy
12,805
+437
+4% +$56.8K 0.23% 73
2023
Q1 		$1.6M Sell
12,368
-2,504
-17% -$328K 0.24% 77
2022
Q4 		$1.95M Sell
14,872
-305
-2% -$39.4K 0.32% 63
2022
Q3 		$1.77M Buy
+15,177
New +$1.88M 0.34% 55
2022
Q1 		– Sell
-1,374
Closed -$210K – 306
2021
Q4 		$210K Buy
+1,374
New +$213K 0.04% 238
2020
Q1 		– Sell
-2,042
Closed -$246K – 614
2019
Q4 		$246K Hold
2,042
– – 0.04% 396
2019
Q3 		$203K Sell
2,042
-299
-13% -$31.3K 0.04% 444
2019
Q2 		$255K Buy
2,341
+30
+1% +$3.19K 0.05% 339
2019
Q1 		$258K Buy
+2,311
New +$253K 0.05% 310

Other funds holding IBB

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Magnus Financial Group's IBB Position: Q2 2026 in Review

Magnus Financial Group increased its iShares Biotechnology ETF (IBB) stake by 9.8% in Q2 2026, buying an estimated $131K and bringing the position to 8,556 shares worth $1.63M. The position accounts for 0.12% of the portfolio, ranked #120.

Magnus Financial Group first reported a position in IBB in Q1 2019 and has held it in 21 quarters since. The position peaked at $1.95M in Q4 2022. 256 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Magnus Financial Group held 8,556 shares of iShares Biotechnology ETF worth $1.63M as of Q2 2026.
  • Magnus Financial Group bought 764 iShares Biotechnology ETF shares in Q2 2026, an estimated $131K.
  • iShares Biotechnology ETF made up 0.12% of Magnus Financial Group's portfolio in Q2 2026, its #120 holding.
  • Magnus Financial Group first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 21 quarters since.
  • Magnus Financial Group's iShares Biotechnology ETF position peaked at $1.95M in Q4 2022.
  • 256 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.